459 related articles for article (PubMed ID: 17476650)
1. Constructing multiple test procedures for partially ordered hypothesis sets.
Edwards D; Madsen J
Stat Med; 2007 Dec; 26(28):5116-24. PubMed ID: 17476650
[TBL] [Abstract][Full Text] [Related]
2. Power and sample size when multiple endpoints are considered.
Senn S; Bretz F
Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
[TBL] [Abstract][Full Text] [Related]
3. A graphical approach to sequentially rejective multiple test procedures.
Bretz F; Maurer W; Brannath W; Posch M
Stat Med; 2009 Feb; 28(4):586-604. PubMed ID: 19051220
[TBL] [Abstract][Full Text] [Related]
4. The fallback procedure for evaluating a single family of hypotheses.
Wiens BL; Dmitrienko A
J Biopharm Stat; 2005; 15(6):929-42. PubMed ID: 16279352
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methods for estimating the number of true null hypotheses in multiplicity testing.
Hsueh HM; Chen JJ; Kodell RL
J Biopharm Stat; 2003 Nov; 13(4):675-89. PubMed ID: 14584715
[TBL] [Abstract][Full Text] [Related]
6. How to deal with multiple endpoints in clinical trials.
Neuhäuser M
Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
[TBL] [Abstract][Full Text] [Related]
7. Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research.
Hommel G; Bretz F; Maurer W
J Biopharm Stat; 2011 Jul; 21(4):595-609. PubMed ID: 21516559
[TBL] [Abstract][Full Text] [Related]
8. A mixture gatekeeping procedure based on the Hommel test for clinical trial applications.
Brechenmacher T; Xu J; Dmitrienko A; Tamhane AC
J Biopharm Stat; 2011 Jul; 21(4):748-67. PubMed ID: 21516567
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity and flexibility in clinical trials.
Brannath W; Koenig F; Bauer P
Pharm Stat; 2007; 6(3):205-16. PubMed ID: 17674349
[TBL] [Abstract][Full Text] [Related]
10. Gatekeeping procedures with clinical trial applications.
Dmitrienko A; Tamhane AC
Pharm Stat; 2007; 6(3):171-80. PubMed ID: 17583553
[TBL] [Abstract][Full Text] [Related]
11. Partition testing in dose-response studies with multiple endpoints.
Liu Y; Hsu J; Ruberg S
Pharm Stat; 2007; 6(3):181-92. PubMed ID: 17654696
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical testing of multiple endpoints in group-sequential trials.
Glimm E; Maurer W; Bretz F
Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
[TBL] [Abstract][Full Text] [Related]
13. A note on tree gatekeeping procedures in clinical trials.
Dmitrienko A; Tamhane AC; Liu L; Wiens BL
Stat Med; 2008 Jul; 27(17):3446-51. PubMed ID: 18484599
[TBL] [Abstract][Full Text] [Related]
14. Memory and other properties of multiple test procedures generated by entangled graphs.
Maurer W; Bretz F
Stat Med; 2013 May; 32(10):1739-53. PubMed ID: 23280780
[TBL] [Abstract][Full Text] [Related]
15. Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests.
Strassburger K; Bretz F
Stat Med; 2008 Oct; 27(24):4914-27. PubMed ID: 18618415
[TBL] [Abstract][Full Text] [Related]
16. Multistage and mixture parallel gatekeeping procedures in clinical trials.
Dmitrienko A; Kordzakhia G; Tamhane AC
J Biopharm Stat; 2011 Jul; 21(4):726-47. PubMed ID: 21516566
[TBL] [Abstract][Full Text] [Related]
17. A note on the power of Fisher's least significant difference procedure.
Meier U
Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
[TBL] [Abstract][Full Text] [Related]
18. Two-stage designs for phase II cancer trials with ordinal responses.
Stallard N; Cockey L
Contemp Clin Trials; 2008 Nov; 29(6):896-904. PubMed ID: 18703164
[TBL] [Abstract][Full Text] [Related]
19. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Wang YC; Chen G; Chi GY
J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
[TBL] [Abstract][Full Text] [Related]
20. Adaptive designs: looking for a needle in the haystack-a new challenge in medical research.
Bauer P
Stat Med; 2008 May; 27(10):1565-80. PubMed ID: 17935261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
